Haemonetics repays $300M of 0.00% convertible notes at maturity

HAEMONETICS CORP

Repaid $300M principal of 0.00% Convertible Senior Notes due 2026 at maturity on March 2, 2026.
Funding came from cash on hand and borrowings under its revolving credit facility.
No holders exercised conversion rights prior to the maturity date.
Capped call transactions entered in connection with the notes expired upon maturity.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.